Moderate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti–Hepatitis C Virus Therapy in Patients With Advanced Liver Disease
Clinical infectious diseases/Clinical infectious diseases (Online. University of Chicago. Press)